Developments in t cell based cancer immunotherapies / edited by Paolo A. Ascierto, David F. Stroncek, Ena Wang.
Tipo de material:
TextoSeries Cancer Drug Discovery and DevelopmentEditor: Cham : Springer International Publishing : Imprint: Humana Press, 2015Edición: 1st ed. 2015Descripción: xv, 305 páginas : 26 ilustraciones en colorTipo de contenido: - texto
- computadora
- recurso en línea
- 9783319211671
- RC261-271
Springer eBooks
1 New insight of peptide vaccination in cancer immunotherapy -- 2 The determinants of T cell function for effective anticancer vaccine -- 3 T cell fate in the tumor microenvironment -- 4 T cell receptor avidity and affinity and tumor specific TCR engineer -- 5 Host genetic variation and somatic alteration associated with favorable or compromised T cell function -- 6 Production of Clinical T Cell Therapies -- 7 Clinical success of adoptive cell transfer therapy using tumor infiltrating lymphocytes.-8 Harnessing stem cell-like memory T cells for adoptive cell transfer therapy of cancer -- 9 T cell blockade- anti-CTLA4 immunotherapy against cancer and Abscopal effect in combination therapy -- 10 T cell modulation- anti-OD-1 antibodies for the treatment of cancer -- 11 T cell based therapies in combination with other procedures -- 12 Chimeric antigen receptor T cells CD19 CAR -- 13 Hematopoietic Stem Cell transplantation as immune therapy of malignancies.
Para consulta fuera de la UANL se requiere clave de acceso remoto.